Qianjiang Yongan Pharmaceutical Co., Ltd.
SZSE:002365.SZ
9.87 (CNY) • At close October 26, 2023
Overview | Financials
Numbers are in millions (except for per share data and ratios) CNY.
2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue
| 972.89 | 1,462.448 | 1,565.409 | 1,172.854 | 1,370.443 | 1,005.408 | 932.772 | 549.4 | 555.894 | 658.417 | 522.718 | 470.698 | 417.015 | 319.729 | 310.299 | 447.488 | 314.988 | 156.704 |
Cost of Revenue
| 721.213 | 980.789 | 1,206.87 | 816.505 | 1,051.724 | 655.372 | 592.465 | 408.445 | 457.315 | 556.786 | 437.77 | 342.641 | 314.437 | 239.386 | 207.579 | 284.424 | 209.967 | 101.32 |
Gross Profit
| 251.677 | 481.658 | 358.539 | 356.348 | 318.719 | 350.036 | 340.306 | 140.954 | 98.579 | 101.632 | 84.948 | 128.056 | 102.578 | 80.343 | 102.72 | 163.064 | 105.021 | 55.384 |
Gross Profit Ratio
| 0.259 | 0.329 | 0.229 | 0.304 | 0.233 | 0.348 | 0.365 | 0.257 | 0.177 | 0.154 | 0.163 | 0.272 | 0.246 | 0.251 | 0.331 | 0.364 | 0.333 | 0.353 |
Reseach & Development Expenses
| 41.501 | 40.449 | 53.044 | 46.663 | 54.417 | 23.982 | 46.474 | 0.985 | 1.856 | 2.022 | 1.412 | 0.404 | 0 | 0 | 0.37 | 0.422 | 0.217 | 0 |
General & Administrative Expenses
| 85.776 | 88.475 | 27.075 | 28.397 | 22.299 | 11.411 | 15.591 | 9.408 | 8.485 | 8.476 | 6.905 | 6.064 | 15.008 | 20.463 | 4.137 | 5.443 | 4.452 | 5.133 |
Selling & Marketing Expenses
| 38.761 | 125.226 | 78.765 | 99.888 | 81.508 | 65.468 | 54.83 | 44.727 | 46.326 | 30.339 | 26.085 | 23.919 | 18.055 | 18.042 | 13.868 | 17.578 | 17.464 | 8.688 |
SG&A
| 174.965 | 213.702 | 105.839 | 128.284 | 103.807 | 76.879 | 70.421 | 54.134 | 54.81 | 38.815 | 32.99 | 29.983 | 33.063 | 38.505 | 18.004 | 23.021 | 21.916 | 13.822 |
Other Expenses
| 28.403 | 66.185 | 69.692 | 43.408 | 43.98 | -0.007 | 4.998 | 11.069 | 7.553 | 5.9 | 5.282 | -1.165 | 3.011 | 4.805 | 2.44 | 1.081 | 1.148 | -0.095 |
Operating Expenses
| 244.869 | 320.336 | 228.574 | 218.355 | 202.204 | 161.569 | 160.167 | 99.693 | 97.298 | 73.301 | 67.863 | 51.262 | 34.057 | 40.755 | 29.061 | 39.053 | 29.725 | 15.232 |
Operating Income
| 5.648 | 152.403 | 131.668 | 133.973 | 117.623 | 212.293 | 151.822 | 62.945 | 13.396 | 32.734 | 22.423 | 89.821 | 77.984 | 46.817 | 72.601 | 119.748 | 71.084 | 38.542 |
Operating Income Ratio
| 0.006 | 0.104 | 0.084 | 0.114 | 0.086 | 0.211 | 0.163 | 0.115 | 0.024 | 0.05 | 0.043 | 0.191 | 0.187 | 0.146 | 0.234 | 0.268 | 0.226 | 0.246 |
Total Other Income Expenses Net
| 0.403 | 0.658 | -1.818 | -3.395 | -1.271 | -0.232 | 5.03 | 10.76 | 7.466 | 4.453 | 5.257 | 12.629 | 14.899 | 12.529 | 1.382 | 1.081 | 0.784 | -0.095 |
Income Before Tax
| 6.052 | 153.061 | 129.851 | 130.578 | 116.352 | 212.061 | 156.853 | 73.328 | 20.862 | 37.187 | 27.679 | 88.656 | 80.995 | 51.622 | 75.041 | 120.829 | 71.868 | 38.447 |
Income Before Tax Ratio
| 0.006 | 0.105 | 0.083 | 0.111 | 0.085 | 0.211 | 0.168 | 0.133 | 0.038 | 0.056 | 0.053 | 0.188 | 0.194 | 0.161 | 0.242 | 0.27 | 0.228 | 0.245 |
Income Tax Expense
| 34.466 | 20.341 | 10.805 | 11.919 | 9.443 | 33.158 | 23.897 | 11.339 | 3.679 | 5.465 | 4.673 | 13.3 | 11.227 | 5.515 | 9.989 | 18.245 | 2.918 | 0.985 |
Net Income
| -12.313 | 140.349 | 111.416 | 105.56 | 89.932 | 178.584 | 133.151 | 62.297 | 17.613 | 31.722 | 23.007 | 75.356 | 69.768 | 46.107 | 65.053 | 102.584 | 68.949 | 37.462 |
Net Income Ratio
| -0.013 | 0.096 | 0.071 | 0.09 | 0.066 | 0.178 | 0.143 | 0.113 | 0.032 | 0.048 | 0.044 | 0.16 | 0.167 | 0.144 | 0.21 | 0.229 | 0.219 | 0.239 |
EPS
| -0.042 | 0.48 | 0.38 | 0.37 | 0.31 | 0.62 | 0.46 | 0.22 | 0.06 | 0.11 | 0.08 | 0.27 | 0.25 | 0.17 | 0.31 | 0.49 | 0.37 | 0.23 |
EPS Diluted
| -0.042 | 0.48 | 0.38 | 0.37 | 0.31 | 0.62 | 0.46 | 0.22 | 0.06 | 0.11 | 0.08 | 0.27 | 0.25 | 0.17 | 0.31 | 0.49 | 0.37 | 0.23 |
EBITDA
| 139.203 | 293.381 | 240.753 | 242.594 | 226.071 | 291.868 | 241.66 | 112.04 | 66.387 | 83.981 | 58.126 | 101.508 | 97.442 | 65.023 | 85.706 | 127.541 | 81.795 | 40.775 |
EBITDA Ratio
| 0.143 | 0.218 | 0.169 | 0.226 | 0.181 | 0.293 | 0.28 | 0.208 | 0.144 | 0.143 | 0.111 | 0.217 | 0.209 | 0.204 | 0.28 | 0.285 | 0.263 | 0.26 |